These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20017601)

  • 21. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir.
    Johnson TJ; Gupta KM; Fabian J; Albright TH; Kiser PF
    Eur J Pharm Sci; 2010 Feb; 39(4):203-12. PubMed ID: 19958831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and delivery of anti-HIV rectal microbicides: advances and challenges.
    Nunes R; Sarmento B; das Neves J
    J Control Release; 2014 Nov; 194():278-94. PubMed ID: 25229988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances on anti-HIV vaginal delivery systems development.
    Antimisiaris SG; Mourtas S
    Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
    AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers.
    Doncel GF; Clark MR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S10-8. PubMed ID: 21109063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future microbicide approaches aimed at preventing HIV infection in women.
    Pozzetto B; Delézay O; Brunon-Gagneux A; Hamzeh-Cognasse H; Lucht F; Bourlet T
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):167-83. PubMed ID: 22339191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
    Lederman MM; Offord RE; Hartley O
    Nat Rev Immunol; 2006 May; 6(5):371-82. PubMed ID: 16639430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates.
    Promadej-Lanier N; Smith JM; Srinivasan P; McCoy CF; Butera S; Woolfson AD; Malcolm RK; Otten RA
    J Med Primatol; 2009 Aug; 38(4):263-71. PubMed ID: 19476564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
    Friend DR
    Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbicides: a new frontier in HIV prevention.
    McGowan I
    Biologicals; 2006 Dec; 34(4):241-55. PubMed ID: 17097303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbicide research: current and future directions.
    Ramjee G
    Curr Opin HIV AIDS; 2010 Jul; 5(4):316-21. PubMed ID: 20543607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
    das Neves J; Amiji M; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
    Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK
    J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbicides for HIV prevention.
    Ramjee G
    Indian J Med Res; 2011 Dec; 134(6):930-8. PubMed ID: 22310825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.